tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCYC Stock Latest News

Bicycle Therapeutics Expands Board with New Appointments
Company AnnouncementsBicycle Therapeutics Expands Board with New Appointments
21d ago
8K
BCYC
Bicycle Therapeutics price target lowered to $10 from $22 at Citizens JMP
PremiumThe Fly
Bicycle Therapeutics price target lowered to $10 from $22 at Citizens JMP
2M ago
BCYC
Bicycle Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Bicycle Therapeutics Reports Q2 2025 Financial Results
2M ago
BCYC
Bicycle Therapeutics price target raised to $27 from $25 at RBC Capital
PremiumThe Fly
Bicycle Therapeutics price target raised to $27 from $25 at RBC Capital
2M ago
BCYC
Bicycle Therapeutics price target lowered to $44 from $48 at Oppenheimer
PremiumThe Fly
Bicycle Therapeutics price target lowered to $44 from $48 at Oppenheimer
2M ago
BCYC
Bicycle Therapeutics: Strategic Restructuring and Promising Pipeline Drive Buy Rating
PremiumRatingsBicycle Therapeutics: Strategic Restructuring and Promising Pipeline Drive Buy Rating
2M ago
BCYC
Bicycle Therapeutics files $500M mixed securities shelf
Premium
The Fly
Bicycle Therapeutics files $500M mixed securities shelf
2M ago
BCYC
Bicycle Therapeutics: Strategic Cost Reduction and Program Advancements Justify Buy Rating
Premium
Ratings
Bicycle Therapeutics: Strategic Cost Reduction and Program Advancements Justify Buy Rating
2M ago
BCYC
Bicycle Therapeutics Appoints Charles Swanton to Board
PremiumCompany Announcements
Bicycle Therapeutics Appoints Charles Swanton to Board
2M ago
8K
BCYC
Bicycle Therapeutics reports Q2 EPS ($1.14), consensus (93c)
PremiumThe Fly
Bicycle Therapeutics reports Q2 EPS ($1.14), consensus (93c)
2M ago
BCYC
Bicycle Therapeutics price target lowered to $25 from $32 at RBC Capital
PremiumThe Fly
Bicycle Therapeutics price target lowered to $25 from $32 at RBC Capital
2M ago
BCYC
Bicycle Therapeutics Approves Proposals at Annual Meeting
PremiumCompany Announcements
Bicycle Therapeutics Approves Proposals at Annual Meeting
3M ago
8K
BCYC
Bicycle Therapeutics price target raised to $17 from $15 at Morgan Stanley
PremiumThe FlyBicycle Therapeutics price target raised to $17 from $15 at Morgan Stanley
5M ago
BCYC
Bicycle Therapeutics: Strong Pipeline Progress and Strategic Expansion Support Buy Rating
Premium
Ratings
Bicycle Therapeutics: Strong Pipeline Progress and Strategic Expansion Support Buy Rating
5M ago
BCYC
Bicycle Therapeutics price target lowered to $14 from $17 at B. Riley
Premium
The Fly
Bicycle Therapeutics price target lowered to $14 from $17 at B. Riley
5M ago
BCYC
Bicycle Therapeutics price target lowered to $22 from $26 at Citizens JMP
PremiumThe Fly
Bicycle Therapeutics price target lowered to $22 from $26 at Citizens JMP
5M ago
BCYC
Bicycle Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
Bicycle Therapeutics Reports Q1 2025 Progress and Financials
5M ago
BCYC
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
PremiumThe Fly
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
5M ago
BCYC
Bicycle Therapeutics: Promising Advancements and Strong Financial Position Justify Buy Rating
PremiumRatings
Bicycle Therapeutics: Promising Advancements and Strong Financial Position Justify Buy Rating
5M ago
BCYC
Promising Developments in Bicycle Therapeutics’ Pipeline Bolster Buy Rating
PremiumRatingsPromising Developments in Bicycle Therapeutics’ Pipeline Bolster Buy Rating
5M ago
BCYC
Bicycle Therapeutics reports Q1 EPS (88c), consensus (81c)
Premium
The Fly
Bicycle Therapeutics reports Q1 EPS (88c), consensus (81c)
5M ago
BCYC
Promising Imaging Data and Future Trials Support Buy Rating for Bicycle Therapeutics
Premium
Ratings
Promising Imaging Data and Future Trials Support Buy Rating for Bicycle Therapeutics
5M ago
BCYC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >